Efficacy and Safety Study of TJCS for Treatment of Moderate to Severe Dry Eye Syndromes
Clinical trial NCT02461719 · COMPLETED
Trial details
- NCT number
- NCT02461719
- Sponsor
- Taejoon Pharmaceutical Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2014-01-01
- Primary completion
- 2014-09-01
- Enrollment
- 158
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.